orthogon
pool
evalu
strategi
rapid
screen
multipl
cystein
serin
proteas
larg
compound
librari
valid
method
human
cystein
proteas
cathepsin
b
screen
librari
individu
compound
also
librari
mix
compound
per
well
orthogon
pool
method
use
result
compound
present
two
well
mix
differ
set
nine
compound
locat
thu
hit
identifi
base
activ
locat
avoid
need
retest
compon
activ
mixtur
hit
test
doserespons
dithiothreitol
dtt
contain
buffer
use
primari
ht
buffer
contain
cystein
place
dtt
rule
artifact
due
oxid
inactiv
enzym
comparison
confirm
activ
singlecompound
mixtur
screen
show
mixtur
screen
identifi
activ
singlecompound
ht
base
result
orthogon
pool
strategi
use
success
rapidli
screen
sever
cystein
serin
proteas
ne
goal
penn
center
molecular
discoveri
philadelphia
pa
develop
capabl
screen
multipl
member
target
class
exampl
cystein
serin
proteas
part
molecular
librari
screen
center
network
mlscn
access
divers
librari
compound
aim
test
entir
mlscn
compound
librari
multipl
cystein
serin
proteas
obtain
profil
activ
enzym
class
profil
may
use
immedi
identifi
select
compound
subsequ
screen
novel
enzym
target
may
also
possibl
identifi
subset
librari
enhanc
hit
rate
toward
enzym
famili
might
provid
basi
gene
famili
screen
one
strategi
enabl
rapid
screen
larg
compound
librari
multipl
target
screen
compound
mixtur
instead
individu
compound
reagent
cost
screen
time
therebi
reduc
significantli
chose
evalu
orthogon
pool
strategi
give
compound
per
well
describ
detail
advantag
method
compound
two
plate
mix
differ
set
nine
compound
locat
duplic
improv
valid
statist
interpret
ht
greatli
simplifi
deconvolut
result
activ
well
contain
given
compound
immedi
identifi
compound
hit
method
use
success
sever
pharmaceut
compani
human
liver
cathepsin
b
ec
chosen
prototyp
cystein
proteas
famili
valid
compound
pool
strategi
cathepsin
b
lysosom
cystein
proteas
involv
mani
physiolog
process
remodel
extracellular
matrix
wound
heal
apoptosi
activ
thyroxin
renin
addit
physiolog
role
cathepsin
b
import
mani
patholog
process
cancer
inflamm
infect
overexpress
secret
cathepsin
b
occur
mani
type
tumor
correl
posit
invas
metastasi
cathepsin
b
facilit
tumor
invas
dissolv
extracellular
matrix
inhibitor
enzym
shown
reduc
tumor
cell
motil
invas
vitro
inhibitor
cathepsin
b
therefor
interest
potenti
anticanc
agent
also
recent
resurg
interest
cathepsin
b
due
research
show
proteolysi
enzym
requir
entri
replic
ebola
sever
acut
respiratori
syndrom
virus
human
cell
studi
confirm
role
cathepsin
b
cathepsin
l
ebola
viru
glycoproteinmedi
infect
cathepsin
b
inhibitor
shown
diminish
multipl
infecti
ebola
viruszair
cultur
cell
may
merit
investig
antiebola
viru
drug
valid
compound
pool
strategi
provid
result
screen
cathepsin
b
use
simpl
endpoint
assay
monitor
releas
fluorophor
aminomethyl
coumarin
amc
upon
enzymat
hydrolysi
amclabel
dipeptid
pool
allow
us
screen
compound
singl
ht
run
also
screen
cathepsin
b
singlecompound
ht
allow
us
compar
hit
profil
obtain
singl
mixtur
screen
import
consider
ensur
activ
compound
discov
singlecompound
screen
also
identifi
mixtur
screen
human
liver
cathepsin
b
catalog
number
purchas
calbiochem
san
diego
ca
substrat
zargargamc
bachem
king
prussia
pa
assay
buffer
compon
amc
standard
purchas
sigmaaldrich
st
loui
mo
lowvolum
nonbind
surfac
black
plate
use
fluoresc
assay
corn
lowel
polypropylen
vbottom
plate
greiner
bioon
monro
nc
use
compound
storag
dilut
heat
seal
appli
use
plateloc
heat
sealer
veloc
menlo
park
ca
polystyren
lid
nunc
rochest
ny
compound
test
suppli
biofocu
dpi
south
san
francisco
ca
part
mlscn
librari
compound
molecular
librari
small
molecul
repositori
ship
dri
ice
biofocu
dpi
frozen
mm
solut
dimethyl
sulfoxid
dmso
heatseal
polypropylen
plate
prior
compound
plate
ship
qualiti
control
qc
test
biofocu
dpi
confirm
compound
solubl
dmso
presenc
expect
molecular
ion
liquid
chromatographymass
spectrometri
lcm
puriti
evapor
light
scatter
ultraviolet
nm
arriv
plate
store
desicc
rel
humid
storag
approxim
month
plate
allow
warm
room
temperatur
desicc
thaw
plate
use
prepar
dilut
plate
singlecompound
mixtur
ht
describ
refrozen
singlecompound
ht
set
mm
dilut
plate
prepar
perkin
elmer
boston
workstat
use
pipet
head
two
microlit
biofocu
dpi
plate
pipet
polypropylen
vbottom
plate
contain
l
per
well
dmso
mix
repeat
aspir
dispens
l
plate
heatseal
store
room
temperatur
week
desicc
prior
use
plate
mixtur
ht
prepar
shown
fig
two
hundr
plate
contain
compound
biofocu
dpi
arrang
two
grid
plate
set
plate
pool
give
singl
mixtur
plate
shown
result
mixtur
plate
per
singlecompound
plate
autom
plate
pool
protocol
set
thermocr
burlington
canada
screen
deck
control
polara
oper
softwar
heat
seal
remov
hand
set
singlecompound
plate
replac
loosefit
polystyren
plate
lid
plate
turn
delid
place
perkin
elmer
workstat
two
microlit
compound
dmso
plate
transfer
pipet
head
dispos
tip
singl
mixtur
plate
give
final
mixtur
volum
l
concentr
mixtur
mm
dmso
mm
per
compound
pipet
complet
plate
immedi
heatseal
minim
exposur
atmospher
moistur
separ
protocol
mixtur
plate
dilut
fourfold
transfer
l
mixtur
l
dmso
give
mixtur
mm
dmso
per
compound
plate
heatseal
store
room
temperatur
day
desicc
prior
use
hit
select
singlecompound
mixtur
ht
cherrypick
set
mm
compound
plate
suppli
biofocu
dpi
compound
transfer
singl
well
row
vbottom
polypropylen
plate
frozen
compound
plate
allow
warm
room
temperatur
desicc
compound
pipet
carri
use
dispos
liquid
level
sens
tip
perkin
elmer
janu
fourtip
workstat
ten
microlit
dmso
ad
row
vbottom
polypropylen
plate
l
select
compound
transfer
one
well
addit
l
dmso
ad
well
follow
l
per
well
dmso
ad
entir
plate
use
thermo
fisher
scientif
waltham
multidrop
compound
twofold
serial
dilut
transfer
l
row
row
row
row
p
use
singl
row
dispos
tip
perkin
elmer
pipet
head
l
discard
row
p
result
doserespons
plate
contain
twofold
dilut
nm
compound
arrang
one
compound
per
column
column
plate
heatseal
store
room
temperatur
day
desicc
prior
use
puriti
integr
compound
identifi
hit
mixtur
singlecompound
ht
analyz
lcm
water
milford
zq
system
forti
microlit
solut
compound
dmso
elut
water
column
mm
gradient
water
formic
acid
acetonitril
formic
acid
compound
integr
puriti
determin
identif
expect
molecular
ion
peak
integr
evapor
light
scatter
ultraviolet
absorb
nm
assay
buffer
consist
mm
sodiumpotassium
phosphat
ph
mm
potassium
phosphat
monobas
mm
sodium
phosphat
monobas
mm
sodium
phosphat
tribas
mm
edta
mm
dithiothreitol
dtt
zargargamc
substrat
serial
dilut
assay
buffer
contain
dmso
l
per
well
dilut
transfer
multichannel
pipett
four
column
lowvolum
assay
plate
cathepsin
b
activ
prior
addit
assay
plate
incub
assay
buffer
min
assay
start
ad
compound
mixtur
ad
pintool
transfer
perkin
elmer
workstat
pintool
v
p
scientif
san
diego
ca
use
transfer
nl
mm
solut
dmso
assay
plate
contain
l
water
per
well
give
final
concentr
compound
assay
dmso
singl
compound
ad
likewis
mm
solut
dmso
give
final
concentr
assay
dmso
qc
plate
contain
cystein
proteas
inhibitor
concentr
nm
obtain
addit
nl
solut
dmso
assay
buffer
consist
mm
sodiumpotassium
phosphat
ph
mm
potassium
phosphat
monobas
mm
sodium
phosphat
monobas
mm
sodium
phosphat
tribas
mm
edta
mm
dtt
cathepsin
b
activ
prior
addit
assay
plate
incub
assay
buffer
min
assay
start
addit
substrat
l
activ
enzym
l
use
multidrop
reagent
dispens
give
final
concentr
nm
cathepsin
b
zargargamc
substrat
dmso
l
assay
buffer
h
room
temperatur
fluoresc
read
envis
micropl
fluorimet
excit
nm
emiss
nm
assay
ident
ht
assay
except
twofold
dilut
compound
test
compound
twofold
serial
dilut
dmso
mm
nm
transfer
pintool
assay
plate
give
final
concentr
rang
nm
dmso
ic
assay
presenc
cystein
dtt
cathepsin
b
assay
buffer
replac
mm
cystein
enzym
activ
cysteinecontain
buffer
h
assay
describ
data
analyz
use
activitybas
idb
ht
plate
contain
individu
compound
mixtur
compound
column
control
enzym
compound
column
blank
enzym
column
percentag
inhibit
calcul
compound
signal
fluoresc
unit
mean
plate
control
plate
blank
use
follow
equat
compound
singlecompound
ht
gave
inhibit
select
hit
retest
doserespons
percentag
inhibit
result
mixtur
ht
retriev
sargen
idb
togeth
ident
individu
compound
within
mixtur
compound
present
two
mixtur
data
rearrang
use
custom
excel
microsoft
redmond
wa
macro
develop
gener
contribut
dr
mandar
ghatnekar
rajaram
gurumurthi
infosi
technolog
ltd
bangalor
india
align
percentag
inhibit
valu
associ
compound
compound
gave
inhibit
mixtur
locat
select
retest
individu
doserespons
doserespons
curv
percentag
activ
fit
xlfit
use
fourparamet
logist
fit
equat
maximum
percentag
activ
minimum
percentag
activ
fix
respect
fluoresc
assay
use
cathepsin
b
screen
ic
confirm
base
previous
publish
protocol
cathepsin
b
purchas
calbiochem
suppli
concentr
gml
appropri
concentr
enzym
assay
room
temperatur
lowvolum
nonbind
surfac
plate
determin
assay
presenc
zargargamc
substrat
dmso
base
serial
dilut
enzym
calbiochem
stock
final
dilut
correspond
nm
enzym
found
give
robust
signal
linear
time
cours
interv
k
zargargamc
substrat
cathepsin
b
dmso
assay
buffer
determin
use
nm
enzym
substrat
concentr
rang
nonlinear
fit
data
fig
gave
k
k
cat
kinet
paramet
consist
valu
respect
previous
report
affinitypurifi
human
cathepsin
b
allow
made
signific
differ
assay
condit
two
studi
ph
temperatur
barico
et
al
compar
ph
room
temperatur
present
studi
cathepsin
b
assay
valid
enzym
inhibit
ht
use
wellknown
cystein
proteas
inhibitor
shown
activ
sitedirect
irrevers
inhibitor
cathepsin
b
doserespons
test
ic
assay
use
studi
gave
ic
nm
fig
thu
concentr
nm
nm
cathepsin
b
observ
inhibit
halflif
min
consist
previous
publish
halflif
obtain
higher
reagent
concentr
nm
nm
cathepsin
b
higher
temperatur
vs
room
temperatur
current
studi
base
ic
result
mixtur
singlecompound
screen
includ
analysi
perform
qc
plate
contain
nm
plate
show
consist
inhibit
robust
coeffici
variat
cv
signalbackground
ratio
repres
exampl
shown
fig
gave
inhibit
control
cv
blank
cv
signalbackground
ratio
mean
controlmean
blank
compound
plate
store
frozen
deliveri
biofocu
dpi
storag
approxim
month
plate
thaw
use
prepar
dilut
plate
singlecompound
mixtur
ht
refrozen
addit
month
ht
hit
cherrypick
origin
compound
plate
thu
compound
undergon
one
freezethaw
cycl
sinc
ht
cherrypick
hit
serial
dilut
dmso
result
doserespons
plate
immedi
heatseal
store
room
temperatur
desicc
day
prior
ic
test
overal
plate
handl
design
minim
exposur
compound
water
reduc
storag
time
much
practic
possibl
rule
compound
degrad
caus
data
inconsist
hit
analyz
puriti
integr
lcm
found
match
compound
origin
analyz
ship
biofocu
dpi
addit
compound
seri
fig
select
hittolead
followup
reorder
biofocu
dpi
newli
deliv
compound
compar
inhous
cherrypick
lcm
ic
test
librari
compound
screen
mixtur
individu
ht
run
includ
two
qc
plate
contain
nm
refer
inhibitor
well
gave
mean
inhibit
also
present
screen
librari
consist
previou
studi
gave
inhibit
singl
compound
mixtur
compon
doserespons
confirm
gave
ic
valu
nm
nm
presenc
dtt
cystein
respect
tabl
compound
complet
singlecompound
screen
plate
assay
day
mixtur
ht
complet
singl
run
plate
gave
least
compound
mixtur
ht
present
two
mixtur
data
rearrang
identifi
individu
compound
show
inhibit
locat
compound
select
hit
hit
threshold
fivefold
larger
mean
cv
plate
control
analysi
hit
singlecompound
ht
defin
compound
exceed
inhibit
threshold
eightfold
mean
cv
plate
control
higher
hit
threshold
use
analysi
singlecompound
ht
compar
mixtur
ht
compar
design
compens
differ
compound
concentr
singlecompound
ht
mixtur
ht
compound
show
inhibit
satur
follow
equat
may
use
estim
ic
percentag
inhibit
observ
singl
screen
concentr
henc
hit
threshold
singl
compound
ht
would
expect
gener
hit
threshold
mixtur
ht
hit
mixtur
singlecompound
ht
cherrypick
mm
master
plate
test
doserespons
nm
full
ht
doserespons
result
mixtur
screen
avail
pubchem
assay
id
singlecompound
result
avail
assay
id
compound
activ
doserespons
presenc
dtt
also
test
cystein
assay
buffer
place
dtt
report
previous
redoxsensit
compound
reduc
dtt
produc
reactiv
oxygen
speci
hydrogen
peroxid
condit
enzym
contain
activesit
cystein
inactiv
thiol
oxid
numer
exampl
compound
react
dtt
thu
caus
enzym
inactiv
show
activ
presenc
cystein
thu
compound
inhibit
cathepsin
b
presenc
dtt
cystein
judg
artifact
tabl
list
compound
confalseposit
rate
mixtur
ht
lower
singlecompound
ht
vs
percentag
base
one
ht
campaign
set
condit
determin
degre
differ
statist
signific
nevertheless
mixtur
ht
appear
reliabl
predictor
compound
activ
subsequ
doserespons
confirm
presum
reflect
statist
valu
screen
mixtur
compon
duplic
rather
one
well
case
singl
compound
ht
import
factor
consid
valid
mixtur
screen
falseneg
rate
thu
address
follow
question
confirm
activ
compound
singlecompound
screen
miss
mixtur
ht
inspect
primari
ht
hit
defin
inhibit
locat
mixtur
ht
inhibit
one
locat
singlecompound
ht
activ
doserespons
defin
ic
margin
doserespons
defin
ic
percentag
inhibit
inact
doserespons
anoth
activ
present
defin
doserespons
test
individu
compound
gave
activ
defin
ic
percentag
inhibit
compound
select
doserespons
test
two
mixtur
origin
gave
percentag
inhibit
mixtur
ht
howev
mixtur
gave
highest
percentag
inhibit
ht
found
also
contain
one
compound
confirm
activ
doserespons
test
inact
doserespons
activ
present
defin
doserespons
test
individu
compound
gave
activ
defin
ic
percentag
inhibit
case
singlecompound
ht
compound
select
doserespons
test
identifi
hit
gave
percentag
inhibit
case
mixtur
ht
compound
select
doserespons
test
two
mixtur
origin
gave
percentag
inhibit
despit
discrep
activ
mixtur
ht
lack
activ
doserespons
none
confirm
activ
compound
present
origin
mixtur
retest
rate
defin
activ
doserespons
percentag
primari
ht
hit
falseposit
rate
defin
inact
doserespons
activ
present
percentag
primari
ht
hit
na
applic
reveal
major
confirm
activ
compound
hit
screen
howev
compound
hit
either
singlecompound
mixtur
ht
extent
overlap
ht
hit
illustr
venn
diagram
fig
confirm
activ
identifi
singlecompound
ht
also
identifi
mixtur
ht
thu
mixtur
screen
miss
four
confirm
activ
singlecompound
screen
howev
analysi
look
significantli
differ
dttreactiv
artifact
exclud
discuss
numer
compound
found
caus
enzym
inactiv
react
dtt
assay
buffer
retest
doserespons
use
cysteinecontain
buffer
remain
confirm
activ
singlecompound
screen
hit
mixtur
ht
thu
exclud
artifact
mixtur
screen
identifi
activ
singlecompound
screen
interestingli
mixtur
ht
identifi
addit
three
compound
classifi
hit
singlecompound
ht
howev
compound
show
inhibit
singlecompound
ht
threshold
use
hit
select
fact
activ
dttreactiv
artifact
correl
well
mixtur
singlecompound
ht
suggest
compound
mixtur
may
modul
reactiv
artifact
affect
either
initi
compound
reduct
dtt
inactiv
cathepsin
b
enzym
reactiv
oxygen
speci
gener
dttcompound
redox
chemistri
inspect
structur
confirm
activ
tabl
allow
us
group
hit
structur
class
fig
exclud
analog
known
cystein
proteas
inhibitor
compound
dttreactiv
artifact
structur
class
remain
seri
aminopyrazol
repres
present
promis
structureact
relationship
ic
valu
rang
furthermor
compound
appear
dttmediat
redox
artifact
access
medicin
chemistri
optim
result
synthesi
test
seri
analog
avail
pubchem
assay
id
full
report
hittolead
effort
publish
screen
compound
mlscn
librari
mixtur
compound
per
well
cathepsin
b
identifi
activ
activ
includ
identifi
singlecompound
screen
cathepsin
b
thu
mixtur
screen
repres
viabl
strategi
ht
proteas
base
valid
use
mixtur
ht
method
profil
mlscn
librari
cystein
proteas
cathepsin
serin
proteas
cathepsin
g
complement
factor
coagul
factor
xia
xiia
